IM Cannabis Corp. (IMCC.CN)
| Previous Close | 1.0900 |
| Open | 1.0300 |
| Bid | 0.9400 x N/A |
| Ask | 1.4500 x N/A |
| Day's Range | 0.9000 - 1.1200 |
| 52 Week Range | 0.2400 - 1.9000 |
| Volume | |
| Avg. Volume | 23,655 |
| Market Cap | 14.6M |
| Beta (5Y Monthly) | 1.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7400 |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.25 |
CNW GroupIM Cannabis Reports First Quarter Financial Results
IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2023, unless otherwise stated.
CNW GroupIM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.
- CNW Group
IMC to transfer its Oranim Pharmacy shares back to the seller
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
